Latest Breaking News On - Yiping zhu - Page 1 : comparemela.com

Price: Scientists atSt. JudeChildren’s Research Hospital are working with colleagues in China to develop better therapy for childhood acute lymphoblastic leukemia (ALL). Results from a large phase 3 noninferiority clinical trial definitively showed that vincristine and dexamethasone pulses can be eliminated in patients with low-risk disease. The findings were published today in The Lancet Oncology. Adding the chemotherapy vincristine plus a steroid (originally prednisone, and later dexamethasone) as pulse therapy for childhood ALL has been part of standard care since the 1970s. This is despite their being associated with neuropsychological side effects, neuropathy and other late effects. However, to date studies about the need for prolonged treatment with pulse therapy have been inconclusive.

Hong kongHua jiangUniversity of hong kongHong kong generalHui jiangHui zhangJing chenJingyan tangAiguo liuJu gaoYingchi zhangWenyu yangChangda liangMinghua yangKaili panRunming jin